Role of HPV in cutaneous premalignant and malignant tumors

Clinics in Dermatology

Volumn 15, Issue 3, 1997, Pages 335-347

  Pfister, Herbert ^a   Ter Schegget, Jan ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; MOUSE; NONHUMAN; ONCOGENE; PRECANCER; PRIORITY JOURNAL; REVIEW; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS STRAIN; WART VIRUS;

EID: 0343907169     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(96)00162-9     Document Type: Article

References (103)

1. Syverton JT. The pathogenesis of the rabbit papillomato-carcinoma sequence. Ann N Y Acad Sci 1952;54:1126-40.
2. Wettstein FO. State of viral DNA and gene expression in benign vs malignant tumors. In: Pfister H, editor. Papillomaviruses and human cancer. Boca Raton, FL: CRC Press, 1990:155-79.
3. Wettstein FO, Stevens JG. Shope papillomavirus DNA is extensively methylated in non-virus-producing neoplasms. Virology 1983;126:493-504.
4. Orth G, Favre M, Breitburd F. Epidermodysplasia verruciformis: a model for the role of papilloma viruses in human cancer. In: M Essex, G Todaro, H zur Hausen, editors. Viruses in naturally occurring cancers. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1980:259-82.
5. Orth G, Jablonska S, Jarzabek-Chorzelska M, et al. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res 1979;39:1074-82.
6. Kremsdorf D, Favre M, Jablonska S, et al. Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol 1984;52:1013-8.
7. Gassenmaier A, Lammel M, Pfister H. Molecular cloning and characterization of the DNAs of human papillomaviruses 19, 20, and 25 from a patient with epidermodysplasia verruciformis. J Virol 1984;52:1019-23.
8. Kanda R, Tanigaki T, Kitano Y, et al. Types of human papillomavirus isolated from Japanese patients with epidermodysplasia verruciformis. Br J Dermatol 1989;121: 463-9.
9. Jacyk WK, de Villiers EM. Epidermodysplasia verruciformis in Africans. Int J Dermatol 1993;32:806-10.
10. Yutsudo M, Tanigaki T, Kanda R, et al. Involvement of human papillomavirus type 20 in epidermodysplasia verruciformis skin carcinogenesis. J Clin Microbiol 1994; 32:1076-8.
11. Orth G. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp 1986;120:157-74.
12. van Voorst Vader PC, Orth G, Dutronquay V, et al. Epidermodysplasia verruciformis. Skin carcinoma containing human papillomavirus type 5 DNA sequences and primary hepatocellular carcinoma associated with chronic hepatitis B virus infection in a patient. Acta Derm Venereol (Stockh) 1986;66:231-6.
13. Ostrow RS, Bender M, Niimura M, et al. Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis. Proc Natl Acad Sci USA 1982; 79:1634-8.
14. Pfister H, Gassenmaier A, Nürnberger F, et al. Human papilloma virus 5-DNA in a carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types. Cancer Res 1983;43:1436-41.
15. Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 1984;83(Suppl):18s-25s.
16. Kiyono T, Hiraiwa A, Ishibashi M. Differences in transforming activity and coded amino acid sequence among E6 genes of several papillomaviruses associated with epidermodysplasia verruciformis. Virology 1992;186: 628-39.
17. Orth G. Epidermodysplasia verruciformis. In: Salzmann NP, Howley PM, editors. The papovaviridae. The papilloma viruses. New York: Plenum Press, 1987:199-235.
18. Yutsudo M, Hakura A. Human papillomavirus type 17 transcripts expressed in skin carcinoma tissue of a patient with epidermodysplasia verruciformis. Int J Cancer 1987;39:586-9.
19. Yabe Y, Tanimura Y, Sakai A, et al. Molecular characteristics and physical state of human papillomavirus DNA change with progressing malignancy: studies in a patient with epidermodysplasia verruciformis. Int J Cancer 1989; 43:1022-8.
20. Grussendorf EI, Gahlen W. Metaplasia of a verruca vulgaris into spinocellular carcinoma. Dermatologica 1975; 150:295-9.
21. Shelley WB, Wood MG. Transformation of the common wart into squamous cell carcinoma in a patient with primary lymphedema. Cancer 1981;48:820-4.
22. Kopelson PL, Nguyen QH, Moy RL. Verruca vulgaris and radiation exposure are associated with squamous cell carcinoma of the finger. J Dermatol Surg Oncol 1994; 20:38-41.
23. Eliezri YD, Silverstein SJ, Nuovo GJ. Occurrence of human papillomavirus type 16 DNA in cutaneous squamous and basal cell neoplasms. J Am Acad Dermatol 1990;23:836-42.
24. Lutzner M, Croissant O, Ducasse MF, et al. A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. J Invest Dermatol 1980;75:353-6.
25. Rüdlinger R, Smith IW, Bunney MH, et al. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986;115:681-92.
26. Gross G, Ellinger K, Roussaki A, et al. Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol 1988;91:43-8.
27. Vitaliano PP, Urbach F. The relative importance of risk factors in nonmelanoma carcinoma. Arch Dermatol 1980; 116:454-6.
28. Frost CA, Green AC. Epidemiology of solar keratoses, [review]. Br J Dermatol 1994;131:455-64.
29. Sillman FH, Sedlis A. Anogenital papillomavirus infetion and neoplasia in immunodeficient women. Obst Gynecol Clin North Am 1987;14:537-58.
30. Hartevelt MM, Bouwes Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990;49:506-9.
31. Bouwes Bavinck JN, Vermeer BJ, Van der Woude FJ, et al. Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 1991;325:843-8.
32. Hardie IR, Strong RW, Hartley LC, et al. Skin cancer in caucasian renal allograft recipients living in a subtropical climate. Surgery 1980;87:177-83.
33. Bouwes Bavinck JN, Gissmann L, Claas FHJ, et al. Relation between skin cancer, humoral responses to human papillomaviruses and HLA class II molecules in renal transplant recipients. J Immunol 1993;151:1579-86.
34. IARC. Working group on the evaluation of carcinogenic risks to humans. Human papillomaviruses. IARC monographs, Lyon 1995;64:196-212.
35. Wilson CA, Holmes SC, Campo MS, et al. Novel variants of human papillomavirus type 2 in warts from immunocompromised individuals. Br J Dermatol 1989;121:571-6.
36. Barr BB, Benton EC, McLaren K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989;1:124-9.
37. Blessing K, McLaren KM, Morris R, et al. Detection of human papillomavirus in skin and genital lesions of renal allograft recipients by in situ hybridization. Histopathology 1990;16:181-5.
38. Hepburn DJ, Divakar D, Bailey RR, et al. Cutaneous manifestations of renal transplantation in a New Zealand population. N Z Med J 1994;107:497-9.
39. Stark LA, Arends MJ, McLaren KM, et al. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J of Cancer 1994;69:222-9.
40. Obalek S, Favre M, Szymanczyk J, et al. Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients. J Invest Dermatol 1992;98:936-41.
41. Shamanin V, Glover M, Rausch C, et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994;54:4610-3.
42. Euvrard S, Chardonnet Y, Pouteil-Noble C, et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993;72:2198-206.
43. Soler C, Chardonnet Y, Allibert P, et al. Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. J Invest Dermatol 1993;101:286-91.
44. Dyall-Smith D, Trowell H, Mark A, et al. Cutaneous squamous cell carcinomas and papillomaviruses in renal transplant recipients: a clinical and molecular biological study. J Dermatol Sci 1991;2:139-46.
45. Lutzner MA, Orth G, Dutronquay V, et al. Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet 1983;2:422-4.
46. De Jong-Tieben LM, Berkhout RJM, Smits HL, et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995;105:367-71.
47. Tieben LM, Berkhout RJ, Smits HL, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol 1994; 131:226-30.
48. Höptl R, Bens G, Wieland U, et al. Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: detection of a new sequence related to epidermodysplasia verruciformis associated types. J Invest Dermatol 1997;108:53-6.
49. Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996;88:802-11.
50. Sau P, McMarlin SL, Sperling LC, et al. Bowen's disease of the nail bed and periungual area. A clinicopathologic analysis of seven cases. Arch Dermatol 1994;130:204-9.
51. Ashinoff R, Li JJ, Jacobson M, Friedman-Kien AE, et al. Detection of human papillomavirus DNA in squamous cell carcinoma of the nail bed and finger determined by polymerase chain reaction. Arch Dermatol 1991;127: 1813-8.
52. Moy RL, Eliezri YD, Nuovo GJ, et al. Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA 1989;261:2669-73.
53. Sanchez-Lanier M, Triplett C, Campion M. Possible role for human papillomavirus 16 in sqamous cell carcinoma of the finger. J Med Virol 1994;44:369-78.
54. Watts SL, Phelps WC, Ostrow RS, et al. Cellular transformation by human papillomavirus DNA in vitro. Science 1984;225:634-6.
55. Iftner T, Bierfelder S, Csapo Z, et al. Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication. J Virol 1988;62:3655-61.
56. Kiyono T, Nagashima K, Ishibashi M. The primary structure of major viral RNA in a rat cell line transfected with type 47 human papillomavirus DNA and the transforming activity of its cDNA and E6 gene. Virology 1989;173: 551-65.
57. Woodworth CD, Doniger J, DiPaolo JA. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol 1989;63:159-64.
58. Schmitt A, Harry JB, Rapp B, et al. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J Virol 1994;68: 7051-9.
59. Hiraiwa A, Kiyono T, Segawa K, et al. Comparative study on E6 and E7 genes of some cutaneous and genital papillomaviruses of human origin for their ability to transform 3Y1 cells. Virology 1993;192:102-11.
60. Steger G, Pfister H. In vitro expressed HPV 8 E6 protein does not bind p53. Arch Virol 1992;125:355-60.
61. Keen N, Elston R, Crawford L. Interaction of the E6 protein of human papillomavirus with cellular proteins. Oncogene 1994;9:1493-9.
62. Kiyono T, Hiraiwa A, Ishii S, et al. Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin. J Virol 1994;68:4656-61.
63. Yamashita T, Segawa K, Fujinaga Y, et al. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8. Oncogene 1993;8:2433-41.
64. Iftner T, Fuchs PG, Pfister H. Two independently transforming functions of human papillomavirus. Curr Top Microbiol Immunol 1989;144:167-73.
65. Fuchs PG, Horn S, Iftner T, et al. Molecular biology of epidermodysplasia verruciformis-associated human papillomaviruses. In: Doerfler W, Böhm P, editors. Virus strategies. Weinheim: Verlag Chemie, 1993:517-29.
66. Stubenrauch F, Malejczyk J, Fuchs PG, et al. Late promoter of human papillomavirus type 8 and its regulation. J Virol 1992;66:3485-93.
67. Stubenrauch F, Leigh IM, Pfister H. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. J Virol 1996;70:119-26.
68. Herber R, Liem A, Pitot H, et al. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol 1996; 70:1873-81.
69. Greenhalgh DA, Wang XJ, Rothnagel JA, et al. Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous, rasHa-activated papillomas. Cell Growth Differ 1994;5:667-75.
70. Auewarakul P, Gissmann L, Cid-Arregui A. Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Mol Cell Biol 1994;14:8250-8.
71. Arbeit JM, Münger K, Howley PM, et al. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol 1994;68:4358-68.
72. Lambert PF, Pan H, Pitot HC, et al. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc Natl Acad Sci USA 1993;90:5583-7.
73. Lacey M, Alpert S, Hanahan D. Bovine papillomavirus genome elicits skin tumors in transgenic mice. Nature 1986;322:609-12.
74. Frazer IH, Leippe DM, Dunn LA, et al. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Cancer Res 1995;55:2635-9.
75. Tinsley JM, Fisher C, Searle PF. Abnormalities of epidermal differentiation associated with expression of the human papillomavirus type 1 early region in transgenic mice. J Gen Virol 1992;73:1251-60.
76. Deau MC, Favre M, Orth G. Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology 1991; 184:492-503.
77. May M, Dong XP, Beyer-Finkler E, et al. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J 1994;13:1460-6.
78. Purdie KJ, Sexton CJ, Proby CM, et al. Malignant transformation of cutaneous lesions in renal allograft patients: A role for human papillomavirus. Cancer Res 1993;53: 5328-33.
79. Miller SJ, Sun T, Lavker RM. Hair follicles, stem cells and skin cancer. J Invest Dermatol 1993;100:288S-94S.
80. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991;88: 10124-8.
81. Freed DL, Eyres KE. Persistent warts protected from immune attack by a blocking factor. Br J Dermatol 1979;100: 731-3.
82. Van der Leest RJ, Zachow KR, Ostrow RS, et al. Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol 1987;123:354-7.
83. Rüdlinger R, Grob R. Papillomavirus infection and skin cancer in renal allograft. Lancet 1989;1:1132-3.
84. Müller M, Kelly G, Fiedler M, et al. Human papillomavirus type 48. J Virol 1989;63:4907-8.
85. Trenfield K, Salmond CA, Pope JH, et al. Southern blot analysis of skin biopsies for human papillomavirus DNA: renal allograft recipients in south-eastern Queensland. Aust J Dermatol 1993;34:71-8.
86. Smith SE, Davis IC, Leshin B, et al. Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients. Arch Dermatol 1993;129:1585-8.
87. McGregor JM, Farthing A, Crook T, et al. Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses. J Am Acad Dermatol 1994;30:701-6.
88. Pelisson I, Chardonnet Y, Euvrard S, et al. Immunohistochemical detection of p53 protein in cutaneous lesions from transplant recipients harbouring human papillomavirus DNA. Virchows Arch 1994;424:623-30.
89. Berkhout RJ, Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995;33:690-5.
90. Obalek S, Favre M, Jablonska S, et al. Human papillomavirus type 2-associated basal cell carcinoma in two immunosuppressed patients. Arch Dermatol 1988;124:930-4.
91. Grimmel M, de Villiers EM, Neumann C, et al. Characterization of a new human papillomavirus (HPV 41) from disseminated warts and detection of its DNA in some skin carcinomas. Int J Cancer 1988;41:5-9.
92. Kawashima M, Favre M, Obalek S, et al. Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses. J Invest Dermatol 1990;95:537-42.
93. Pierceall WE, Goldberg LH, Ananthaswamy HN. Presence of human papilloma virus type 16 DNA sequences in human nonmelanoma skin cancers. J Invest Dermatol 1991;97:880-4.
94. Ikenberg H, Gissmann L, Gross G, et al. Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer 1983;32: 563-5.
95. Pfister H, Gassenmaier A, Fuchs PG. Demonstration of human papillomavirus DNA in two keratoacanthomas. Arch Dermatol Res 1986;278:243-6.
96. Rüdlinger R, Grob R, Yu YX, et al. Human papillomavirus-35-positive bowenoid papulosis of the anogenital area and concurrent human papillomavirus-35-positive verruca with bowenoid dysplasia of the periungual area. Arch Dermatol 1989;125:655-9.
97. Kettler AH, Rutledge M, Tschen JA, et al. Detection of human papillomavirus in nongenital Bowen's disease by in situ DNA hybridization. Arch Dermatol 1990;126:777-81.
98. Pfister H, Haneke E. Demonstration of human papilloma virus type 2 DNA in Bowen's disease. Arch Dermatol Res 1984;276:123-5.
99. Scheurlen W, Gissmann L, Gross G, et al. Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int J Cancer 1986;37:505-10.
100. Trowell HE, Dyall-Smith ML, Dyall-Smith DJ. Human papillomavirus associated with keratoacanthomas in Australian patients. Arch Dermatol 1990;126:1654.
101. Lu S, Syrjänen K, Havu VK, et al. Known HPV types have no association with keratoacanthomas. Arch Dermatol Res 1996;288:129-32.
102. Lu S, Syrjänen K, Havu VK, et al. No evidence of human papillomavirus DNA in actinic keratosis. Arch Dermatol Res 1995;287:649-51.
103. Fuchs PG, Iftner T, Weninger J et al. Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis. J Virol 1986;58: 626-34.